Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Xetra  >  CytoTools AG    T5O   DE000A0KFRJ1

Real-time Quote. Real-time Tradegate - 05/04 05:36:28 pm
12.123 EUR   -2.23%
04/27 CYTOTOOLS : DermaTools signs contracts for production by a new Germa..
02/03 CYTOTOOLS : strenghthens DermaTools Biotech GmbH with a  capital inc..
2015 CYTOTOOLS : DermaPro retains its potential
 SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Xetra
04/28/2016 04/29/2016 05/02/2016 05/03/2016 05/04/2016 Date
12.5(c) 12(c) 12.76(c) 12.4(c) 12.15 Last
1 290 15 740 4 737 1 815 164 Volume
-2.80% -4.00% +6.33% -2.82% -2.02% Change
More quotes
Financials (€)
Sales 2015 1,50 M
EBIT 2015 -2,60 M
Net income 2015 -2,60 M
Finance 2015 0,20 M
Yield 2015 -
Sales 2016 2,60 M
EBIT 2016 -1,30 M
Net income 2016 -1,30 M
Debt 2016 0,50 M
Yield 2016 -
P/E ratio 2015 -
P/E ratio 2016
EV / Sales 2015 15,6x
EV / Sales 2016 9,25x
Capitalization 23,6 M
More Financials
Company
CytoTools AG operates as a biotechnology company, which develops therapeutic from research on programmed death cell.The company was founded by Dirk Kaiser and Mark-Andre Freyberg in 2000 and is headquartered in Darmstadt, Germany. 
More about the company
Latest news on CYTOTOOLS AG
04/27 CYTOTOOLS : DermaTools signs contracts for production by a new German manufactur..
04/22 DGAP-NEWS : DermaTools Biotech GmbH identifiziert neuen Hersteller für Wirkstoff..
02/03 CYTOTOOLS : strenghthens DermaTools Biotech GmbH with a  capital increase
02/03 CYTOTOOLS : stärkt das Tochterunternehmen DermaTools Biotech GmbH durch Kapitale..
01/26 CYTOTOOLS : klärt die Ursachen der zu geringen Wirkstoffkonzentration auf, die z..
2015 CYTOTOOLS : DermaPro retains its potential
2015 CYTOTOOLS : berichtet: Der Wirkstoff DermaPro(R) behält sein Potential (DGAP New..
2015 CYTOTOOLS : berichtet über Ergebnisse der europäischen klinischen Studie Phase I..
More news
Sector news : Bio Therapeutic Drugs
08:10p Sanofi sees 'strong strategic' fit with U.S. Medivation
05:56p Levi & Korsinsky, LLP Announces Investigation as to Whether the Sale of IMS H..
03:15pINCYTE CORPORATION : quaterly earnings release
More sector news : Bio Therapeutic Drugs


Comments 
Advertisement
Chart CYTOTOOLS AG
Duration : Period :
CytoTools AG Technical Analysis Chart | T5O | DE000A0KFRJ1 | 4-Traders
Full-screen chart
Technical analysis trends CYTOTOOLS AG
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions